XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Changes in Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Total Stockholders’ equity
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Equity (Deficit)
Operating Partnership unitholders’ non-controlling interests
Beginning balance at Dec. 31, 2020 $ 119,639 $ 91,990 $ 95 $ 100,812   $ (8,917) $ 27,649
Beginning balance (in shares) at Dec. 31, 2020     9,464,403        
Net proceeds from sale of common stock 53,240 53,240 $ 37 53,203      
Net proceeds from sale of common stock (in shares)     3,737,500        
Issuance and amortization of equity-based compensation 1,116 886 $ 1 885     230
Issuance and amortization of equity-based compensation (in shares)     149,121        
Issuance and amortization under ESPP 66 66   66      
Issuance and amortization under ESPP (in shares)     3,987        
Restricted stock withholdings (21) (21)   (21)      
Restricted stock withholdings (in shares)     (1,291)        
Dividends declared (3,566) (2,916)       (2,916) (650)
Net income 126 103       103 23
Reallocation of non-controlling interest 0 (3,831)   (3,831)     3,831
Ending balance at Mar. 31, 2021 170,600 139,517 $ 133 151,114 $ 0 (11,730) 31,083
Ending balance (in shares) at Mar. 31, 2021     13,353,720        
Beginning balance at Dec. 31, 2020 119,639 91,990 $ 95 100,812   (8,917) 27,649
Beginning balance (in shares) at Dec. 31, 2020     9,464,403        
Net income 1,624            
Ending balance at Sep. 30, 2021 188,418 147,228 $ 137 163,314 310 (16,533) 41,190
Ending balance (in shares) at Sep. 30, 2021     13,709,282        
Beginning balance at Mar. 31, 2021 170,600 139,517 $ 133 151,114 0 (11,730) 31,083
Beginning balance (in shares) at Mar. 31, 2021     13,353,720        
Net proceeds from sale of common stock 6,053 6,053 $ 3 6,050      
Net proceeds from sale of common stock (in shares)     319,702        
Issuance of OP Units in connection with a transactions 9,021           9,021
Issuance and amortization of equity-based compensation 780 499   499     281
Issuance and amortization of equity-based compensation (in shares)     17,102        
Issuance and amortization under ESPP 8 8   8      
Restricted stock withholdings (221) (221)   (221)      
Restricted stock withholdings (in shares)     (10,906)        
Dividends declared (3,619) (2,951)       (2,951) (668)
Net income 823 671       671 152
Reallocation of non-controlling interest 0 2,611   2,611     (2,611)
Ending balance at Jun. 30, 2021 $ 183,445 146,187 $ 136 160,061 0 (14,010) 37,258
Ending balance (in shares) at Jun. 30, 2021     13,679,618        
Common stock dividend declared (in dollars per share) $ 0.2175            
Net proceeds from sale of common stock $ 409 409 $ 1 408      
Net proceeds from sale of common stock (in shares)     25,015        
Issuance of OP Units in connection with a transactions 6,480           6,480
Issuance and amortization of equity-based compensation 821 495   495     326
Issuance and amortization of equity-based compensation (in shares)     (468)        
Issuance and amortization under ESPP 88 88   88      
Issuance and amortization under ESPP (in shares)     5,117        
Dividends declared (3,895) (3,054)       (3,054) (841)
Accumulated other comprehensive income 394 310         84
Net income 676 531       531 145
Reallocation of non-controlling interest 0 2,262   2,262     (2,262)
Ending balance at Sep. 30, 2021 $ 188,418 147,228 $ 137 163,314 310 (16,533) 41,190
Ending balance (in shares) at Sep. 30, 2021     13,709,282        
Common stock dividend declared (in dollars per share) $ 0.22            
Other Comprehensive Income (Loss), Tax         310    
Beginning balance at Dec. 31, 2021 $ 265,473 220,042 $ 186 237,969 766 (18,879) 45,431
Beginning balance (in shares) at Dec. 31, 2021     18,591,627        
Issuance of OP Units in connection with a transactions 3,238           3,238
Issuance and amortization of equity-based compensation 1,799 1,428 $ 2 1,426     371
Issuance and amortization of equity-based compensation (in shares)     199,102        
Issuance and amortization under ESPP 100 100   100      
Issuance and amortization under ESPP (in shares)     5,387        
Restricted stock withholdings (62) (62)   (62)      
Restricted stock withholdings (in shares)     (3,492)        
Dividends declared (5,197) (4,295)       (4,295) (902)
Accumulated other comprehensive income 2,511            
Net income 721 595       595 126
Reallocation of non-controlling interest 0 346   346     (346)
Ending balance at Mar. 31, 2022 $ 268,583 220,226 $ 188 239,779 2,838 (22,579) 48,357
Ending balance (in shares) at Mar. 31, 2022     18,792,624        
Common stock dividend declared (in dollars per share) $ 0.2275            
Other Comprehensive Income (Loss), Tax   2,072     2,072   439
Beginning balance at Dec. 31, 2021 $ 265,473 220,042 $ 186 237,969 766 (18,879) 45,431
Beginning balance (in shares) at Dec. 31, 2021     18,591,627        
Net income 3,036            
Ending balance at Sep. 30, 2022 278,075 224,130 $ 190 245,793 7,581 (29,434) 53,945
Ending balance (in shares) at Sep. 30, 2022     19,041,777        
Beginning balance at Mar. 31, 2022 268,583 220,226 $ 188 239,779 2,838 (22,579) 48,357
Beginning balance (in shares) at Mar. 31, 2022     18,792,624        
Issuance of OP Units in connection with a transactions 1,987           1,987
Issuance and amortization of equity-based compensation 984 618 $ 0 618     366
Issuance and amortization of equity-based compensation (in shares)     (471)        
Issuance and amortization under ESPP 2 2   2      
Restricted stock withholdings (221) (221)   (221)      
Restricted stock withholdings (in shares)     (14,590)        
Dividends declared (5,305) (4,342)       (4,342) (963)
Accumulated other comprehensive income 504            
Net income 1,165 953       953 212
Reallocation of non-controlling interest 0 225   225     (225)
Ending balance at Jun. 30, 2022 $ 267,699 217,873 $ 188 240,403 3,250 (25,968) 49,826
Ending balance (in shares) at Jun. 30, 2022     18,777,563        
Common stock dividend declared (in dollars per share) $ 0.23            
Other Comprehensive Income (Loss), Tax   412     412   92
Net proceeds from sale of common stock $ 3,507 3,507 $ 2 3,505      
Net proceeds from sale of common stock (in shares)     227,473        
Issuance of OP Units in connection with a transactions 4,713           4,713
Issuance and amortization of equity-based compensation 1,005 620 $ 0 620     385
Issuance and amortization of equity-based compensation (in shares)     28,711        
Issuance and amortization under ESPP 117 117   117      
Issuance and amortization under ESPP (in shares)     8,030        
Dividends declared (5,468) (4,397)       (4,397) (1,071)
Accumulated other comprehensive income 5,352            
Net income 1,150 931       931 219
Reallocation of non-controlling interest 0 1,148   1,148     (1,148)
Ending balance at Sep. 30, 2022 $ 278,075 224,130 $ 190 $ 245,793 7,581 $ (29,434) 53,945
Ending balance (in shares) at Sep. 30, 2022     19,041,777        
Common stock dividend declared (in dollars per share) $ 0.2325            
Other Comprehensive Income (Loss), Tax   $ 4,331     $ 4,331   $ 1,021